The nation of Zimbabwe has rejected a substantial US healthcare agreement worth $367m (272 million pounds) over five years due to Washington's demand for sensitive biological samples.
The decision was revealed after a government memo dated December was disclosed, which showed President Emmerson Mnangagwa believed the deal was "skewed".
A government representative later clarified that the United States was requesting health data for scientific study and commercial gain but was not willing to guarantee the benefits from any future medical innovations.
"We must now begin the challenging and unfortunate process of winding down our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had provided more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for further negotiations to find a deal suitable to both sides so the nation's critical HIV treatment initiative can proceed.
Broader Implications
This rejection follows a similar case in neighbouring Kenya, where a high court halted a related deal with the US after legal challenges were raised about the security of Kenyans' health data.
Since returning to the presidency recently, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
USAID had administered aid for the American government, but Trump claimed its spending was "wasteful" and his administration was seeking government-to-government agreements to enhance transparency and accountability.
According to statements, 16 African countries have so far signed these new agreements, representing over $18.3bn in new funding.
Details of the Declined Agreement
The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation would have delivered extraordinary benefits for Zimbabwean communities, particularly the 1.2 million presently receiving HIV treatment through US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, with no equivalent assurance of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.
"Put simply, our country would supply the raw materials for scientific discovery with no assurance that the final treatments would be accessible to our people should a future disease outbreak emerge."
National Interest and Global Health
He also said that the US's withdrawal from the global health body and its pursuit of one-on-one deals were disrupting systems already established through the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing system designed to manage future global health emergencies.
"This mechanism is intended to ensure that when a nation provides its samples, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
The government's concerns over the US deal "should not be misconstrued as hostility towards the US," he added.
"We welcome ongoing dialogue with our American counterparts on how subsequent co-operation might be structured in a way that respects the sovereignty and dignity of each country."
Medical Community Response
Medical experts stated it understood the government's concerns, but urged that talks must proceed given that a large portion of the nation's Aids initiatives were funded by external financing.
"In cases where specific concerns arise, including those relating to data governance or implementation frameworks, these can frequently be addressed via technical clarification and negotiated safeguards," the group added.
The situation highlights the complex challenges between accepting vital international aid and protecting national sovereignty in an increasingly interconnected world.